Laurie J. Hall Trustee’s Teva Pharmaceuticals TEVA Stock Holding History

Laurie J. Hall Trustee’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-240	Closed	-$5K	–	362
2017 Q4	$5K	Hold	240	–	–	﹤0.01%	328
2017 Q3	$4.22K	Hold	240	–	–	﹤0.01%	284
2017 Q2	$7.97K	Sell	240 -150	-38%	-$4.64K	0.01%	262
2017 Q1	$12.5K	Hold	390	–	–	0.01%	233
2016 Q4	$14K	Buy	+390	New	+$15.6K	0.01%	221
2016 Q2	$20K	Hold	390	–	–	0.01%	200
2016 Q1	$22K	Hold	390	–	–	0.01%	179
2015 Q4	$22K	Buy	+390	New	+$24.1K	0.02%	173

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurie J. Hall Trustee's TEVA Position: Q1 2018 in Review

Laurie J. Hall Trustee sold out of Teva Pharmaceuticals (TEVA) in Q1 2018, closing a stake of 240 shares — an estimated $5K sold.

Laurie J. Hall Trustee first reported a position in TEVA in Q4 2015 and held it in 8 quarters. The position peaked at $22K in Q1 2016. 506 funds tracked by Wall St. Rank hold TEVA as of Q1 2018.

Laurie J. Hall Trustee reported no remaining Teva Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Laurie J. Hall Trustee sold 240 Teva Pharmaceuticals shares in Q1 2018, an estimated $5K.
Laurie J. Hall Trustee first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 8 quarters.
Laurie J. Hall Trustee's Teva Pharmaceuticals position peaked at $22K in Q1 2016.
506 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2018.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2018, filed 10 May 2018.